Incorporation of poison center services in a state-wide overdose education and naloxone distribution program

American Journal on Addictions

Volumn 25, Issue 4, 2016, Pages 301-306

  Doyon, Suzanne ^a   Benton, Carleigh ^b   Anderson, Bruce A ^c   Baier, Michael ^d   Haas, Erin ^d   Hadley, Lisa ^d   Maehr, Jennifer ^e   Rebbert Franklin, Kathleen ^d   Olsen, Yngvild ^f   Welsh, Christopher ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^d Behavioral Health Consulting   (United States)

^e Maryland Department of Juvenile Services   (United States)

^f Institutes for Behavior Resources   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CLONAZEPAM; DIAMORPHINE; METHADONE; MORPHINE; NALOXONE; OPIATE; OXYCODONE; NARCOTIC ANALGESIC AGENT; NARCOTIC ANTAGONIST;

ADOLESCENT; ADULT; AGED; ARTICLE; ASSISTED VENTILATION; BRAIN HEMORRHAGE; CYANOSIS; DEATH; DRUG OVERDOSE; FEMALE; FOLLOW UP; HEALTH EDUCATION; HEALTH PROGRAM; HEALTH SERVICE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POISON CENTER; PRESCRIPTION; RESPIRATION DEPRESSION; RETROSPECTIVE STUDY; SUICIDE ATTEMPT; DRUG DEPENDENCE TREATMENT; EVALUATION STUDY; MARYLAND; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PREVENTIVE HEALTH SERVICE; PROCEDURES; PROGRAM EVALUATION; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANALGESICS, OPIOID; DRUG OVERDOSE; FEMALE; HUMANS; MALE; MARYLAND; MIDDLE AGED; NALOXONE; NARCOTIC ANTAGONISTS; POISON CONTROL CENTERS; PREVENTIVE HEALTH SERVICES; PROGRAM EVALUATION; RETROSPECTIVE STUDIES; SUBSTANCE ABUSE TREATMENT CENTERS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84971484592     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1111/ajad.12384     Document Type: Article

References (30)

1. Warner M, Chen LH, Makuc D, et al. Drug poisoning deaths in the United States, 1980-2008. Centers for disease control and prevention NCHS data brief, number 81 (http://www.cdc.gov/nchs/data/databriefs/db81.htm) (accessed 25.05.2015)
2. http://www.cdc.gov/nchs/data/nvsr/nvsr64/nvsr64-02.pdf (Accessed 25.05.2015)
3. Calcaterra S, Glanz J, Binswanger IA. National trends in pharmaceutical opioid related overdose deaths compares to other substance related overdose deaths: 1999-2009. Drug Alcohol Depend. 2013;131:263-270
4. CDC. WONDER (database), Atlanta, GA. US Department of Health and Human Services, CDC; 2012. http://wonder.cdc.gov/mcd-icd10.html (accessed 25.05.2015)
5. Centers for Disease Control and Prevention CDC grand rounds: Prescription drug overdoses-A U.S. epidemic. MMWR. 2012;61:10-13
6. Wheeler E, Davidson PJ, Jones S, et al. Community-based opioid overdose prevention programs providing naloxone-United States, 2010. MMWR. 2012;61:101-105
7. Davis CS, Ruiz S, Glynn P, et al. Expanded access to naloxone among firefighters, LE officers and emergency medical technicians in Massachusetts. Am J Public Health. 2014;104:e7-e9
8. Ray B, O'Donnell D, Kahre K. LE officer attitudes towards intranasal naloxone training. Drug Alcohol Depend. 2015;146:107-110
9. Orkin MA, Bingham K, Buick JE, et al. Quality assessment errors and study misclassification threaten systematic review validity: Community opioid overdose prevention and naloxone distribution programs review. J Addict Med. 2015;9:502-503
10. Piper TM, Stancliff S, Rudenstine S, et al. Evaluation of a naloxone distribution administration program in New York City. Subst Use Misuse. 2008;43:858-870
11. Enteen L, Bauer J, McLean R, et al. Overdose prevention and naloxone prescription for opioid users in San Francisco. J Urban Health. 2010;87:931-941
12. Loimer N, Hofmann P, Choudhry HR. Nasal administration of naloxone for detection of opiate dependence. J Psychiatr Res. 1992;26:39-43
13. Loimer N, Hofmann P, Choudhry HR. Nasal administration of naloxone is as effective as the intravenous route in opiate addicts. Int J Addict. 1994;29:819-827
14. Kelly AM, Koutsogiannis Z. Intranasal naloxone for life-threatening opioid overdose. Emerg Med J. 2002;19:375
15. Seal KH, Thawley R, Gee L, et al. Naloxone distribution and cardiopulmonary resuscitation training for injection drug users to prevent heroin overdose death: A pilot intervention study. J Urban Health. 2005;82:303-311
16. Maxwell S, Bigg D, Stanczykiewicz K, et al. Prescribing naloxone to actively injecting heroin users: A program to reduce heroin overdose deaths. J Addict Dis. 2006;25:89-96
17. Tobin KA, Sherman SG, Beilenson P, et al. Evaluation of the Staying Alive programme: Training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131-136
18. Doe-Simkins M, Walley AY, Epstein A, et al. Saved by the nose: Bystander-administered Intranasal naloxone hydrochloride for opioid overdose. Am J Public Health. 2009;99:788-790
19. Benett AS, Bell A, Tomedi L, et al. Characteristics of an overdose prevention response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania. J Urban Health. 2011;88:1020-1030
20. Walley A, Xuan Z, Hackman HH, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ. 2013; 346: 174. 1-12
21. Walley AY, Doe-Simkins M, Quinn E, et al. Opioid overdose prevention with intranasal naloxone among people who take methadone. J Subst Abuse Treat. 2013;44:241-247
22. Su A, Brason FW, Sanford C, et al. Project Lazarus: Community-based overdose prevention in Rurual North Carolina. Pain Med. 2011;12: S77-S85
23. American Association of Poison Control Centers National Poison Data System NPDS . accessed November 12 2015. http://www.aapcc.org/datasystem/ npds-elements
24. Leece PN, Hopkins S, Marchall C, et al. Development and implementation of an opioid overdose and response program in Toronto, Ontario. Can J Public Health. 2013;104:e200-e204
25. Kerr T, Fairbairn N, Tyndall M, et al. Predictors of non-fatal overdose among a cohort of polysubstance-using injection drug users. Drug Alcohol Depend. 2007;87:39-45
26. Robertson TM, Hendey GW, Stroh G, et al. Intranasal naloxone is a viable alternative to intravenous naloxone for prehospital narcotic overdose. Prehosp Emerg Care. 2009;13:512-515
27. Buajordet I, Naess AC, Jacobsen D, et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Euro J Emerg Med. 2004;11:19-23
28. Wagner KD, Valente TW, Casanova M, et al. Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA. Int J Drug Policy. 2010;21: 186-193
29. Kerr D, Kelly AM, Dietze P, et al. Randomized controlled trial comparing effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose. Addiction. 2009;104:2067-2074
30. Maryland Department of Health and Mental Hygiene website on the Overdose Response Program accessed November 2015. http://bha.dhmh. maryland.gov/NALOXONE/SitePages/Home.aspx